One gene, many neuropsychiatric disorders: lessons from Mendelian diseases

[1]  Evan E. Eichler,et al.  A Genotype-First Approach to Defining the Subtypes of a Complex Disease , 2014, Cell.

[2]  E. Banks,et al.  De novo mutations in schizophrenia implicate synaptic networks , 2014, Nature.

[3]  D. Maclaurin,et al.  Flash Memory: Photochemical Imprinting of Neuronal Action Potentials onto a Microbial Rhodopsin , 2014, Journal of the American Chemical Society.

[4]  T. Mackay.  Epistasis and quantitative traits: using model organisms to study gene–gene interactions , 2013, Nature Reviews Genetics.

[5]  Wei Niu,et al.  Coexpression Networks Implicate Human Midfetal Deep Cortical Projection Neurons in the Pathogenesis of Autism , 2013, Cell.

[6]  S. Horvath,et al.  Integrative Functional Genomic Analyses Implicate Specific Molecular Pathways and Circuits in Autism , 2013, Cell.

[7]  S. Djurovic,et al.  Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia , 2013, Molecular Psychiatry.

[8]  S. Hyman,et al.  Progress in the Genetics of Polygenic Brain Disorders: Significant New Challenges for Neurobiology , 2013, Neuron.

[9]  Thomas R. Insel,et al.  Twenty-Five Years of Progress: The View from NIMH and NINDS , 2013, Neuron.

[10]  Charles F. Bearden,et al.  A Nondegenerate Code of Deleterious Variants in Mendelian Loci Contributes to Complex Disease Risk , 2013, Cell.

[11]  Nicholas E. Propson,et al.  Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis , 2013, Proceedings of the National Academy of Sciences.

[12]  Jianxin Shi,et al.  Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs , 2013, Nature Genetics.

[13]  Michael R. Johnson,et al.  De novo mutations in the classic epileptic encephalopathies , 2013, Nature.

[14]  D. Goldstein,et al.  Genic Intolerance to Functional Variation and the Interpretation of Personal Genomes , 2013, PLoS genetics.

[15]  L. Siever,et al.  Spatial and Temporal Mapping of De Novo Mutations in Schizophrenia to a Fetal Prefrontal Cortical Network , 2013, Cell.

[16]  Damian Smedley,et al.  Genome-wide Generation and Systematic Phenotyping of Knockout Mice Reveals New Roles for Many Genes , 2013, Cell.

[17]  D. Goldstein,et al.  Sequencing studies in human genetics: design and interpretation , 2013, Nature Reviews Genetics.

[18]  Murim Choi,et al.  De novo mutations in histone modifying genes in congenital heart disease , 2013, Nature.

[19]  Yi-Ju Li,et al.  Mutations in SCO2 are associated with autosomal-dominant high-grade myopia. , 2013, American journal of human genetics.

[20]  M. Daly,et al.  Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis , 2013, The Lancet.

[21]  I. Gottesman,et al.  The Epigenetic Perspective , 2013 .

[22]  真田 昌.  骨髄異形成症候群のgenome-wide analysis , 2013 .

[23]  M C O'Donovan,et al.  The ENCODE project: implications for psychiatric genetics , 2013, Molecular Psychiatry.

[24]  David L. Nelson,et al.  The Unstable Repeats—Three Evolving Faces of Neurological Disease , 2013, Neuron.

[25]  M. Digilio,et al.  Congenital heart defects in recurrent reciprocal 1q21.1 deletion and duplication syndromes: rare association with pulmonary valve stenosis. , 2013, European journal of medical genetics.

[26]  Le Cong,et al.  Multiplex Genome Engineering Using CRISPR/Cas Systems , 2013, Science.

[27]  M. Spira,et al.  Multi-electrode array technologies for neuroscience and cardiology. , 2013, Nature nanotechnology.

[28]  B. V. van Bon,et al.  Diagnostic exome sequencing in persons with severe intellectual disability. , 2012, The New England journal of medicine.

[29]  D. Horn,et al.  Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study , 2012, The Lancet.

[30]  S. Levy,et al.  De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia , 2012, Nature Genetics.

[31]  D. Rujescu,et al.  Copy number variations in neurodevelopmental disorders , 2012, Progress in Neurobiology.

[32]  Ben Lehner,et al.  Beyond genotype to phenotype: why the phenotype of an individual cannot always be predicted from their genome sequence and the environment that they experience , 2012, The FEBS journal.

[33]  E. Bertini,et al.  Spinal muscular atrophy associated with progressive myoclonic epilepsy is caused by mutations in ASAH1. , 2012, American journal of human genetics.

[34]  David B. Goldstein,et al.  De novo mutations in ATP1A3 cause alternating hemiplegia of childhood , 2012, Nature Genetics.

[35]  Patrick F. Sullivan,et al.  Genetic architectures of psychiatric disorders: the emerging picture and its implications , 2012, Nature Reviews Genetics.

[36]  Kenny Q. Ye,et al.  De Novo Gene Disruptions in Children on the Autistic Spectrum , 2012, Neuron.

[37]  Michael F. Walker,et al.  De novo mutations revealed by whole-exome sequencing are strongly associated with autism , 2012, Nature.

[38]  Evan T. Geller,et al.  Patterns and rates of exonic de novo mutations in autism spectrum disorders , 2012, Nature.

[39]  Bradley P. Coe,et al.  Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations , 2012, Nature.

[40]  Matthew J. Thomas,et al.  Proximal microdeletions and microduplications of 1q21.1 contribute to variable abnormal phenotypes , 2012, European Journal of Human Genetics.

[41]  N. Wray,et al.  Impact of diagnostic misclassification on estimation of genetic correlations using genome-wide genotypes , 2012, European Journal of Human Genetics.

[42]  Claudio Carta,et al.  A restricted spectrum of mutations in the SMAD4 tumor-suppressor gene underlies Myhre syndrome. , 2012, American journal of human genetics.

[43]  A. Munnich,et al.  Mutations at a single codon in Mad homology 2 domain of SMAD4 cause Myhre syndrome , 2011, Nature Genetics.

[44]  J. Lupski,et al.  Clan Genomics and the Complex Architecture of Human Disease , 2011, Cell.

[45]  S. Lok,et al.  Increased exonic de novo mutation rate in individuals with schizophrenia , 2011, Nature Genetics.

[46]  Reinhard Ullmann,et al.  Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1 , 2011, BMC Medical Genetics.

[47]  D. Licatalosi,et al.  FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism , 2011, Cell.

[48]  D. Rujescu,et al.  Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder , 2011, Molecular Psychiatry.

[49]  Patrizia Sola,et al.  Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALS , 2011, Neuron.

[50]  G. Cutting.  Modifier genes in Mendelian disorders: the example of cystic fibrosis , 2010, Annals of the New York Academy of Sciences.

[51]  E. Morrow,et al.  Genomic copy number variation in disorders of cognitive development. , 2010, Journal of the American Academy of Child and Adolescent Psychiatry.

[52]  Frank W. Stearns.  One Hundred Years of Pleiotropy: A Retrospective , 2010, Genetics.

[53]  J. Rosenfeld,et al.  Recurrent 200-kb deletions of 16p11.2 that include the SH2B1 gene are associated with developmental delay and obesity , 2010, Genetics in Medicine.

[54]  Stephan J Sanders,et al.  Whole exome sequencing identifies recessive WDR62 mutations in severe brain malformations , 2010, Nature.

[55]  N. Carter,et al.  Distinct effects of allelic NFIX mutations on nonsense-mediated mRNA decay engender either a Sotos-like or a Marshall-Smith syndrome. , 2010, American journal of human genetics.

[56]  Michael R. Johnson,et al.  Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes. , 2010, American journal of human genetics.

[57]  S. Nabuurs,et al.  PRPS1 mutations: four distinct syndromes and potential treatment. , 2010, American journal of human genetics.

[58]  Yiping Shen,et al.  Deletions of NRXN1 (Neurexin-1) Predispose to a Wide Spectrum of Developmental Disorders , 2010, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[59]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[60]  Alexander van Oudenaarden,et al.  Variability in gene expression underlies incomplete penetrance , 2009, Nature.

[61]  D. Rujescu,et al.  Neurexin 1 (NRXN1) deletions in schizophrenia. , 2009, Schizophrenia bulletin.

[62]  P. Visscher,et al.  Common polygenic variation contributes to risk of schizophrenia and bipolar disorder , 2009, Nature.

[63]  T. Kojima,et al.  Physicochemical property changes of amino acid residues that accompany missense mutations in SCN1A affect epilepsy phenotype severity , 2009, Journal of Medical Genetics.

[64]  K. Tory,et al.  Hypomorphic mutations in meckelin (MKS3/TMEM67) cause nephronophthisis with liver fibrosis (NPHP11) , 2009, Journal of Medical Genetics.

[65]  P. Stankiewicz,et al.  Microdeletion 15q13.3: a locus with incomplete penetrance for autism, mental retardation, and psychiatric disorders , 2009, Journal of Medical Genetics.

[66]  Elvira Bramon,et al.  Disruption of the neurexin 1 gene is associated with schizophrenia. , 2009, Human molecular genetics.

[67]  J. Schuurs-Hoeijmakers,et al.  Extending the phenotype of recurrent rearrangements of 16p11.2: deletions in mentally retarded patients without autism and in normal individuals. , 2009, European journal of medical genetics.

[68]  G. Plant,et al.  Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies , 2009, Acta Neuropathologica.

[69]  C. Baker,et al.  Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. , 2008, The New England journal of medicine.

[70]  Thomas W. Mühleisen,et al.  Large recurrent microdeletions associated with schizophrenia , 2008, Nature.

[71]  G. Rouleau,et al.  Mutations in the nervous system--specific HSN2 exon of WNK1 cause hereditary sensory neuropathy type II. , 2008, The Journal of clinical investigation.

[72]  J A Veltman,et al.  CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy , 2008, Molecular Psychiatry.

[73]  T. Watts.  The Pathogenesis of Autism , 2008, Clinical medicine. Pathology.

[74]  Fikret Erdogan,et al.  Array CGH identifies reciprocal 16p13.1 duplications and deletions that predispose to autism and/or mental retardation , 2007, Human mutation.

[75]  Eric J. Nestler,et al.  Epigenetic regulation in psychiatric disorders , 2007, Nature Reviews Neuroscience.

[76]  Hussain Jafri,et al.  An SCN9A channelopathy causes congenital inability to experience pain , 2006, Nature.

[77]  B. Blencowe.  Alternative Splicing: New Insights from Global Analyses , 2006, Cell.

[78]  A. Munnich,et al.  Mutations in PHD‐like domain of the ATRX gene correlate with severe psychomotor impairment and severe urogenital abnormalities in patients with ATRX syndrome , 2006, Clinical genetics.

[79]  J. Lupski,et al.  Curcumin treatment abrogates endoplasmic reticulum retention and aggregation-induced apoptosis associated with neuropathy-causing myelin protein zero-truncating mutants. , 2005, American journal of human genetics.

[80]  S. Dib-Hajj,et al.  Erythromelalgia: A hereditary pain syndrome enters the molecular era , 2005, Annals of neurology.

[81]  Arturas Petronis,et al.  Phenotypic differences in genetically identical organisms: the epigenetic perspective. , 2005, Human molecular genetics.

[82]  Jan Bressler,et al.  Epigenetics and human disease. , 2004, Annual review of genomics and human genetics.

[83]  J. Lupski,et al.  Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations , 2004, Nature Genetics.

[84]  K. Fischbeck,et al.  Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. , 2003, American journal of human genetics.

[85]  S. Gregory,et al.  Mutation of TBCE causes hypoparathyroidism–retardation–dysmorphism and autosomal recessive Kenny–Caffey syndrome , 2002, Nature Genetics.

[86]  Robert J. Unwin,et al.  Human Hypertension Caused by Mutations in WNK Kinases , 2001, Science.

[87]  Joseph H. Nadeau,et al.  Modifier genes in mice and humans , 2001, Nature Reviews Genetics.

[88]  D. Higgs,et al.  Molecular-clinical spectrum of the ATR-X syndrome. , 2000, American journal of medical genetics.

[89]  D. Parsons,et al.  Intragenic telSMN mutations: frequency, distribution, evidence of a founder effect, and modification of the spinal muscular atrophy phenotype by cenSMN copy number. , 1998, American journal of human genetics.

[90]  S. Kish,et al.  Dystonia with motor delay in compound heterozygotes for GTP‐cyclohydrolase I gene mutations , 1998, Annals of neurology.

[91]  R. Desnick,et al.  Molecular Cloning and Characterization of a Full-length Complementary DNA Encoding Human Acid Ceramidase , 1996, The Journal of Biological Chemistry.

[92]  S. Tsuji,et al.  Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene , 1994, Nature Genetics.

[93]  K. Fischbeck,et al.  Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy , 1991, Nature.

[94]  Mckusick Va.  Phenotypic diversity of human diseases resulting from allelic series. , 1973 .

[95]  A. Chess.  Random and Non-Random Monoallelic Expression , 2013, Neuropsychopharmacology.

[96]  De novo mutations in epileptic encephalopathies , 2013 .

[97]  R. Tibshirani,et al.  (37) Medications as Independent Risk Factors of Delirium in Patients With COVID-19: A Retrospective Study , 2018, Journal of the Academy of Consultation-Liaison Psychiatry.

[98]  The HRDAutosomal Recessive Kenny–Caffey Syndrome Consortium.  Mutation of TBCE causes hypoparathyroidism– retardation–dysmorphism and autosomal recessive Kenny–Caffey syndrome , 2002 .

[99]  H. Dietz,et al.  Nonsense-mediated mRNA decay in health and disease. , 1999, Human molecular genetics.

[100]  V. McKusick.  Phenotypic diversity of human diseases resulting from allelic series. , 1973, American journal of human genetics.